Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in Acta Derm Venereol

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    November 2022
  1. BOESJES CM, Kamphuis E, Zuithoff NPA, Bakker DS, et al
    Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
    Acta Derm Venereol. 2022;102:adv00820.
    PubMed     Abstract available


  2. TIZEK L, Wecker H, Schneider S, Johansson EK, et al
    Eczema-related Web Search Data in Sweden: Investigating Search Patterns and the Influence of Weather.
    Acta Derm Venereol. 2022;102:adv00810.
    PubMed     Abstract available


  3. KIM DC, Choi YW, Lee ES, Choi JW, et al
    No Association Between First Exposure to General Anaesthesia and Atopic Dermatitis in the Paediatric Population.
    Acta Derm Venereol. 2022 Nov 1. doi: 10.2340/actadv.v102.2738.
    PubMed     Abstract available


    October 2022
  4. MERHAND S, Thenie C, Taieb C
    Family Impact of Atopic Dermatitis in Children Under Six Years of Age: A French Evaluation.
    Acta Derm Venereol. 2022 Oct 25. doi: 10.2340/actadv.v102.2562.
    PubMed    


  5. JWO JY, Chiou K, Tsai J, Huang YC, et al
    Efficacy of Acupuncture for Treatment of Atopic Eczema and Chronic Eczema: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2022;102:adv00791.
    PubMed    


  6. IVERT LU, Svedbom A, Lundqvist M, Wahlgren CF, et al
    The Impact of Systemic Treatment for Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study.
    Acta Derm Venereol. 2022 Oct 3. doi: 10.2340.
    PubMed     Abstract available


  7. BRADLEY M, Svensson A
    Increased Knowledge-based Care is Indicated for Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Oct 3. doi: 10.2340/actadv.v102.4576.
    PubMed    


    September 2022
  8. LUHERNE C, Menguy S, Ferte T, Beylot-Barry M, et al
    A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sezary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
    Acta Derm Venereol. 2022;102:adv00773.
    PubMed     Abstract available


    August 2022
  9. MOSE AP, Adwa U, Svedman C
    Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa.
    Acta Derm Venereol. 2022 Aug 16. doi: 10.2340/actadv.v102.3425.
    PubMed    


    July 2022
  10. JOHANSSON EK, Brenneche A, Trangbaek D, Stelmaszuk MN, et al
    Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.1986.
    PubMed     Abstract available


  11. SEDEH FB, Henning MAS, Jemec GBE, Ibler KS, et al
    Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.2075.
    PubMed     Abstract available


  12. OLESEN CM, Clausen ML, Agner T, Asplund M, et al
    Altered Maturation of the Skin Bacterial Communities in Infants with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.2275.
    PubMed     Abstract available


    June 2022
  13. SANCHEZ-DIAZ M, Salazar-Nievas MC, Molina-Leyva A, Arias-Santiago S, et al
    Type D Personality Is Associated with Poorer Quality of Life in Patients with Chronic Spontaneous Urticaria: A Cross-sectional Study.
    Acta Derm Venereol. 2022;102:adv00734.
    PubMed     Abstract available


  14. HEDEGAARD PLIESS LARSEN H, Vittrup I, Frier Ruge I, Elberling J, et al
    Severe and ChRonic ATopic Dermatitis CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340.
    PubMed     Abstract available


  15. WANG M, Zheng Q, Tang S, Shen F, et al
    Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.2245.
    PubMed    


  16. SALAVA A, Rieppo R, Lauerma A, Salo V, et al
    Age-dependent Distribution of Atopic Dermatitis in Primary Care: A Nationwide Population-based Study from Finland.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.2287.
    PubMed     Abstract available


  17. WU L, Ali K, Qiu Y, Li M, et al
    Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.1079.
    PubMed    


    May 2022
  18. OSAWA K, Kiniwa Y, Shimosato Y, Midorikawa H, et al
    Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy.
    Acta Derm Venereol. 2022;102:adv00723.
    PubMed    


  19. MIYAMOTO S, Imai Y, Natsuaki M, Yamanishi K, et al
    Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab.
    Acta Derm Venereol. 2022 May 17. doi: 10.2340.
    PubMed    


    April 2022
  20. GERNER T, Rasmussen Rinnov M, Halling AS, Haarup Ravn N, et al
    Differences in Occurrence, Risk Factors and Severity of Early-onset Atopic Dermatitis among Preterm and Term Children.
    Acta Derm Venereol. 2022 Apr 26. doi: 10.2340.
    PubMed     Abstract available


  21. WOLLENBERG A, Marcoux D, Silverberg J, Aoki V, et al
    Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Apr 8. doi: 10.2340.
    PubMed     Abstract available


  22. THOMSEN SF, Pritzier EC, Anderson CD, Juvik S, et al
    Treatment Patterns and Clinical Outcomes of Chronic Urticaria: Two-year Follow-up Results from the Scandinavian AWARE Study.
    Acta Derm Venereol. 2022;102:adv00689.
    PubMed     Abstract available


    March 2022
  23. LUNDIN S, Bergstrom A, Wahlgren CF, Johansson EK, et al
    Living with Atopic Dermatitis as a Young Adult in Relation to Health-related Quality of Life and Healthcare Contacts: A Population-based Study.
    Acta Derm Venereol. 2022 Mar 21. doi: 10.2340.
    PubMed     Abstract available


  24. CREPY MN, Bensefa-Colas L, Aubin F, Simon M, et al
    Vocational Guidance for Young Atopic Dermatitis Patients: A Survey of Physicians' Opinions and Practices.
    Acta Derm Venereol. 2022 Mar 1. doi: 10.2340.
    PubMed     Abstract available


    February 2022
  25. BATINAC T, Hlaca N, Simetic L, Valkovic F, et al
    Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma.
    Acta Derm Venereol. 2022;102:adv00650.
    PubMed    


    January 2022
  26. ACHTEN RE, Van Luijk C, Van der Rijst L, Bakker D, et al
    Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jan 31. doi: 10.2340/actadv.v101.1128.
    PubMed     Abstract available


  27. KIYOHARA T, Fukudome T, Kamio Y, Koike Y, et al
    Clinical Course of Atopic Dermatitis in an Adult with Amyotrophic Lateral Sclerosis: Etiologic Implications of Voluntary Movements and Dermatitis Severity.
    Acta Derm Venereol. 2022 Jan 28. doi: 10.2340/actadv.v101.1121.
    PubMed    


  28. ROGNER D, Biedermann T, Lauffer F
    Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.
    Acta Derm Venereol. 2022 Jan 27. doi: 10.2340/actadv.v101.1088.
    PubMed    


  29. TAYEFI M, Bradley M, Neijber A, Fastberg A, et al
    Chronic Urticaria: A Swedish Registry-based Cohort Study on Population, Comorbidities and Treatment Characteristics.
    Acta Derm Venereol. 2022;102:adv00624.
    PubMed     Abstract available


    December 2021
  30. HUPPOP F, Dahnhardt-Pfeiffer S, Folster-Holst R
    Characterization of Classical Flexural and Nummular Forms of Atopic Dermatitis in Childhood with Regard to Anamnestic, Clinical and Epidermal Barrier Aspects.
    Acta Derm Venereol. 2021 Dec 22. doi: 10.2340.
    PubMed     Abstract available


  31. QIU Y, Ali K, Lou H, Shan J, et al
    Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin's Lymphoma.
    Acta Derm Venereol. 2021 Dec 14. doi: 10.2340.
    PubMed    


  32. JU Y, Li M, Lu X, Zhao C, et al
    Skin Picking in Atopic Dermatitis and Psoriasis Patients: A Single-centre Cross-sectional Study in China.
    Acta Derm Venereol. 2021 Dec 14. doi: 10.2340.
    PubMed    


    November 2021
  33. STAUMONT D, Taieb C, Merhand S, Shourick J, et al
    The Atopic Dermatitis Control Tool, A High-Performance Tool for Optimal Support.
    Acta Derm Venereol. 2021 Nov 29. doi: 10.2340.
    PubMed     Abstract available


  34. MITRI F, Toberer F, Enk AH, Hartmann M, et al
    Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine.
    Acta Derm Venereol. 2021;101:adv00596.
    PubMed    


  35. NYMAN GSA, Gimenez-Arnau AM, Grigaitiene J, Malinauskiene L, et al
    Patch Testing with Propolis of Different Geographical Origins in a Baseline Series.
    Acta Derm Venereol. 2021;101:adv00591.
    PubMed     Abstract available


    October 2021
  36. KWIATKOWSKA D, Reich A
    Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis.
    Acta Derm Venereol. 2021;101:adv00583.
    PubMed     Abstract available


  37. NAKAHARA T, Kido-Nakahara M, Onozuka D, Sakai S, et al
    Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study.
    Acta Derm Venereol. 2021 Oct 28. doi: 10.2340.
    PubMed    


  38. TAKEOKA S, Kamata M, Yokoi I, Takehara A, et al
    Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.
    Acta Derm Venereol. 2021;101:adv00581.
    PubMed    


  39. SILVERBERG JI, Simpson EL, Boguniewicz M, De Bruin-Weller MS, et al
    Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
    Acta Derm Venereol. 2021 Oct 7. doi: 10.2340.
    PubMed     Abstract available


    September 2021
  40. WEISS D, Nordhorn I, Tizek L, Werfel T, et al
    Prescription Behaviour and Barriers to Prescription of Biologicals for Treatment of Chronic Inflammatory Skin Diseases in Dermatological Practice in Two German Federal States.
    Acta Derm Venereol. 2021;101:adv00560.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: